Oncolytics Biotech Inc (ONC) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.899x

Based on the latest financial reports, Oncolytics Biotech Inc (ONC) has a cash flow conversion efficiency ratio of -0.899x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-5.47 Million ≈ $-3.96 Million USD) by net assets (CA$6.09 Million ≈ $4.40 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Oncolytics Biotech Inc - Cash Flow Conversion Efficiency Trend (1999–2024)

This chart illustrates how Oncolytics Biotech Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read ONC total debt and obligations for a breakdown of total debt and financial obligations.

Oncolytics Biotech Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Oncolytics Biotech Inc ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Excelliance MOS
TWO:5299
0.024x
Bank Dinar Indonesia Tbk PT
JK:DNAR
0.024x
SKYX Platforms Corp
NASDAQ:SKYX
-4.846x
Cashbil
JSE:CSB
0.288x
Limes Schlosskliniken AG
XETRA:LIK
0.135x
Leifheit Aktiengesellschaft
F:LEI
0.097x
DongKook Pharmaceutical Co. Ltd
KQ:086450
0.031x
PT Satu Visi Putra Tbk
JK:VISI
-0.009x

Annual Cash Flow Conversion Efficiency for Oncolytics Biotech Inc (1999–2024)

The table below shows the annual cash flow conversion efficiency of Oncolytics Biotech Inc from 1999 to 2024. For the full company profile with market capitalisation and key ratios, see Oncolytics Biotech Inc (ONC) market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CA$5.98 Million
≈ $4.33 Million
CA$-26.97 Million
≈ $-19.51 Million
-4.507x -336.69%
2023-12-31 CA$27.56 Million
≈ $19.94 Million
CA$-28.45 Million
≈ $-20.58 Million
-1.032x -17.12%
2022-12-31 CA$26.50 Million
≈ $19.17 Million
CA$-23.36 Million
≈ $-16.89 Million
-0.881x -41.80%
2021-12-31 CA$36.10 Million
≈ $26.11 Million
CA$-22.43 Million
≈ $-16.23 Million
-0.621x +30.29%
2020-12-31 CA$24.75 Million
≈ $17.91 Million
CA$-22.07 Million
≈ $-15.96 Million
-0.892x -100.48%
2019-12-31 CA$-107.89K
≈ $-78.05K
CA$-19.91 Million
≈ $-14.40 Million
184.497x +9688.95%
2018-12-31 CA$6.20 Million
≈ $4.48 Million
CA$-11.92 Million
≈ $-8.62 Million
-1.924x -7.03%
2017-12-31 CA$8.28 Million
≈ $5.99 Million
CA$-14.89 Million
≈ $-10.77 Million
-1.798x -54.00%
2016-12-31 CA$10.69 Million
≈ $7.73 Million
CA$-12.48 Million
≈ $-9.03 Million
-1.167x -91.56%
2015-12-31 CA$24.67 Million
≈ $17.85 Million
CA$-15.03 Million
≈ $-10.88 Million
-0.609x +57.21%
2014-12-31 CA$13.82 Million
≈ $10.00 Million
CA$-19.68 Million
≈ $-14.23 Million
-1.424x -29.41%
2013-12-31 CA$22.21 Million
≈ $16.07 Million
CA$-24.44 Million
≈ $-17.68 Million
-1.100x +52.51%
2012-12-31 CA$14.79 Million
≈ $10.70 Million
CA$-34.26 Million
≈ $-24.78 Million
-2.317x -203.39%
2011-12-31 CA$29.52 Million
≈ $21.35 Million
CA$-22.54 Million
≈ $-16.31 Million
-0.764x -77.55%
2010-12-31 CA$41.93 Million
≈ $30.33 Million
CA$-18.03 Million
≈ $-13.05 Million
-0.430x +16.02%
2009-12-31 CA$32.84 Million
≈ $23.76 Million
CA$-16.82 Million
≈ $-12.17 Million
-0.512x +68.33%
2008-12-31 CA$9.45 Million
≈ $6.84 Million
CA$-15.29 Million
≈ $-11.06 Million
-1.617x -233.25%
2007-12-31 CA$27.96 Million
≈ $20.23 Million
CA$-13.57 Million
≈ $-9.82 Million
-0.485x -22.97%
2006-12-31 CA$30.80 Million
≈ $22.28 Million
CA$-12.16 Million
≈ $-8.79 Million
-0.395x -58.73%
2005-12-31 CA$44.45 Million
≈ $32.16 Million
CA$-11.05 Million
≈ $-8.00 Million
-0.249x -3.47%
2004-12-31 CA$38.39 Million
≈ $27.77 Million
CA$-9.22 Million
≈ $-6.67 Million
-0.240x -9.74%
2003-12-31 CA$25.02 Million
≈ $18.10 Million
CA$-5.48 Million
≈ $-3.96 Million
-0.219x +50.03%
2002-12-31 CA$16.56 Million
≈ $11.98 Million
CA$-7.26 Million
≈ $-5.25 Million
-0.438x -63.61%
2001-12-31 CA$15.95 Million
≈ $11.54 Million
CA$-4.27 Million
≈ $-3.09 Million
-0.268x -68.90%
2000-12-31 CA$19.92 Million
≈ $14.41 Million
CA$-3.16 Million
≈ $-2.28 Million
-0.159x -105.58%
1999-12-31 CA$6.93 Million
≈ $5.01 Million
CA$-534.35K
≈ $-386.54K
-0.077x --

About Oncolytics Biotech Inc

TO:ONC Canada Biotechnology
Market Cap
$1.08 Billion
CA$1.50 Billion CAD
Market Cap Rank
#17830 Global
#576 in Canada
Share Price
CA$14.90
Change (1 day)
-1.32%
52-Week Range
CA$0.45 - CA$18.60
All Time High
CA$18.60
About

Oncolytics Biotech Inc., a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of oncology treatments. The company develops pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of hormone receptor-positive / human epidermal growth factor 2-negative advanced and metastatic breast cancer, metastatic pancreatic ductal aden… Read more